glp 1 and hair loss in females GLP-1 therapies loss: A systematic review of current evidence and implications for counseling GLP-1 Medications & Hair Loss:

This study examines the initial and long-term costs of GLP-1 s compared to bariatric surgery

(HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agonist designed for once-monthly subcutaneous dosing in obesity treatment.

Recapping the headlines that affected American's health in 2025

Brand Name: Retatrutide Pen Strength: Triple Agonist for GLP-1, GIP, and Glucagon Receptors Manufacturer: Regenmed Price: On Request Retatrutide must always be used under the supervision of a Registered Medical Practitioner (RMP)

We're proud to already support thousands of patients using medications like Ozempic, Mounjaro, and Zepbound